Overview Dividends

(MCS) Marcus - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5663301068

Theatres, Hotels, Resorts, Management, Laundry

MCS EPS (Earnings per Share)

EPS Growth (3Y CAGR): 24.05%
EPS Trend (3Y Correlation): 8.5%

MCS Revenue

Revenue Growth (3Y CAGR): 4.27%
Revenue Trend (3Y Correlation): 14.6%

Description: MCS Marcus October 23, 2025

The Marcus Corporation (NYSE:MCS) is a diversified hospitality and entertainment operator headquartered in Milwaukee. Through its Marcus Theatres, Movie Tavern, and BistroPlex brands, it runs multiscreen movie theaters and a family entertainment center, while its hotel segment includes full-service properties, managed resorts, and condominium-hotel contracts, complemented by ancillary services such as commercial laundry and vacation-ownership management.

Key metrics from recent filings show FY 2023 revenue of roughly $1.5 billion, with the theater segment contributing about 55 % and hotels 45 %. Occupancy rates for its hotels have been trending upward, reaching an average RevPAR of $96, while theater attendance has recovered to ~80 % of pre-pandemic levels, reflecting improved discretionary spending as inflation pressures ease.

Sector drivers that materially affect MCS include consumer confidence (which influences movie-going and travel demand), competition from streaming platforms, and macro-economic trends such as fuel prices that impact travel behavior. Monitoring these variables is essential for forecasting future earnings.

For a deeper, data-driven valuation of MCS, you might explore the analyst tools on ValueRay.

MCS Stock Overview

Market Cap in USD	419m
Sub-Industry	Movies & Entertainment
IPO / Inception	1990-03-29

MCS Stock Ratings

Growth Rating	-34.1%
Fundamental	47.8%
Dividend Rating	66.5%
Return 12m vs S&P 500	-34.1%
Analyst Rating	4.75 of 5

MCS Dividends

Dividend Yield 12m	2.19%
Yield on Cost 5y	4.06%
Annual Growth 5y	13.29%
Payout Consistency	88.4%
Payout Ratio	64.4%

MCS Growth Ratios

Growth Correlation 3m	-42.1%
Growth Correlation 12m	-83.2%
Growth Correlation 5y	-7.1%
CAGR 5y	-1.27%
CAGR/Max DD 3y (Calmar Ratio)	-0.03
CAGR/Mean DD 3y (Pain Ratio)	-0.07
Sharpe Ratio 12m	-0.11
Alpha	-38.71
Beta	1.011
Volatility	35.64%
Current Volume	281k
Average Volume 20d	220k
Stop Loss	12.6 (-4.8%)
Signal	-0.10

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (14.8m TTM) > 0 and > 6% of Revenue (6% = 46.5m TTM)

FCFTA -0.00 (>2.0%) and ΔFCFTA -2.15pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -15.33% (prev -12.92%; Δ -2.41pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.08 (>3.0%) and CFO 79.4m > Net Income 14.8m (YES >=105%, WARN >=100%)

Net Debt (396.4m) to EBITDA (92.5m) ratio: 4.29 <= 3.0 (WARN <= 3.5)

Current Ratio 0.24 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (31.5m) change vs 12m ago -2.20% (target <= -2.0% for YES)

Gross Margin 76.71% (prev 39.15%; Δ 37.56pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 75.01% (prev 65.10%; Δ 9.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 1.87 (EBITDA TTM 92.5m / Interest Expense TTM 11.7m) >= 6 (WARN >= 3)

Altman Z'' 0.70

(A) -0.12 = (Total Current Assets 37.6m - Total Current Liabilities 156.5m) / Total Assets 1.02b

(B) 0.25 = Retained Earnings (Balance) 251.2m / Total Assets 1.02b

(D) 0.50 = Book Value of Equity 283.4m / Total Liabilities 567.9m

Total Rating: 0.70 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 47.82

1. Piotroski 5.0pt = 0.0

2. FCF Yield -0.55% = -0.27

3. FCF Margin -0.58% = -0.22

4. Debt/Equity 0.40 = 2.42

5. Debt/Ebitda 4.29 = -2.50

6. ROIC - WACC (= -2.67)% = -3.34

7. RoE 2.48% = 0.21

8. Rev. Trend 14.58% = 1.09

9. EPS Trend 8.49% = 0.42

What is the price of MCS shares?

As of October 31, 2025, the stock is trading at USD 13.23 with a total of 281,000 shares traded.
Over the past week, the price has changed by -1.78%, over one month by -14.20%, over three months by -18.47% and over the past year by -21.75%.

Is Marcus a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Marcus (NYSE:MCS) is currently (October 2025) a stock to sell. It has a ValueRay Fundamental Rating of 47.82 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MCS is around 12.08 USD . This means that MCS is currently overvalued and has a potential downside of -8.69%.

Is MCS a buy, sell or hold?

Marcus has received a consensus analysts rating of 4.75. Therefore, it is recommended to buy MCS.

Strong Buy: 3
Buy: 1
Hold: 0
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the MCS price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	23.3	75.7%
Analysts Target Price	23.3	75.7%
ValueRay Target Price	13.1	-1.2%

MCS Fundamental Data Overview October 27, 2025

Market Cap USD = 419.3m (419.3m USD * 1.0 USD.USD)
P/E Trailing = 28.4894
P/E Forward = 32.4675
P/S = 0.5704
P/B = 1.0669
P/EG = 4.1111
Beta = 1.011
Revenue TTM = 775.8m USD
EBIT TTM = 21.8m USD
EBITDA TTM = 92.5m USD
Long Term Debt = 170.1m USD (from longTermDebt, last quarter)
Short Term Debt = 47.5m USD (from shortTermDebt, last quarter)
Debt = 411.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 396.4m USD (from netDebt column, last quarter)
Enterprise Value = 815.6m USD (419.3m + Debt 411.3m - CCE 14.9m)
Interest Coverage Ratio = 1.87 (Ebit TTM 21.8m / Interest Expense TTM 11.7m)
FCF Yield = -0.55% (FCF TTM -4.47m / Enterprise Value 815.6m)
FCF Margin = -0.58% (FCF TTM -4.47m / Revenue TTM 775.8m)
Net Margin = 1.91% (Net Income TTM 14.8m / Revenue TTM 775.8m)
Gross Margin = 76.71% ((Revenue TTM 775.8m - Cost of Revenue TTM 180.7m) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 31.76%)
Tobins Q-Ratio = 0.80 (Enterprise Value 815.6m / Total Assets 1.02b)
Interest Expense / Debt = 0.72% (Interest Expense 2.98m / Debt 411.3m)
Taxrate = 27.28% (2.75m / 10.1m)
NOPAT = 15.8m (EBIT 21.8m * (1 - 27.28%))
Current Ratio = 0.24 (Total Current Assets 37.6m / Total Current Liabilities 156.5m)
Debt / Equity = 0.40 (Debt 411.3m / totalStockholderEquity, last quarter 1.02b)
Debt / EBITDA = 4.29 (Net Debt 396.4m / EBITDA 92.5m)
Debt / FCF = -88.72 (negative FCF - burning cash) (Net Debt 396.4m / FCF TTM -4.47m)
Total Stockholder Equity = 596.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.46% (Net Income 14.8m / Total Assets 1.02b)
RoE = 2.48% (Net Income TTM 14.8m / Total Stockholder Equity 596.3m)
RoCE = 2.84% (EBIT 21.8m / Capital Employed (Equity 596.3m + L.T.Debt 170.1m))
RoIC = 2.51% (NOPAT 15.8m / Invested Capital 632.1m)
WACC = 5.18% (E(419.3m)/V(830.5m) * Re(9.74%) + D(411.3m)/V(830.5m) * Rd(0.72%) * (1-Tc(0.27)))
Discount Rate = 9.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.38%
Fair Price DCF = unknown (Cash Flow -4.47m)
EPS Correlation: 8.49 | EPS CAGR: 24.05% | SUE: -1.73 | # QB: 0
Revenue Correlation: 14.58 | Revenue CAGR: 4.27% | SUE: 0.44 | # QB: 0

Additional Sources for MCS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle